Peptides & Peptide Synthesis Products

Fmoc-D-Asp-OtBu

Fmoc-D-Asp-OtBu

$400.00
$400.00
Fmoc-D-Asp-OtBu, Catalog No: 42054
(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid, CAS: 134098-70-7, MW: 411.45, Formula: C23H25NO6
Catalog No: 42054
(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid, CAS: 134098-70-7, MW: 411.45, Formula: C23H25NO6
Description

Details

(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
Additional Information

Additional Information

Catalog Number 42054
CAS 134098-70-7
M.W. 411.45
Formula C23H25NO6
IUPAC Name (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
Synonym No
Also Known As
  • (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
  • (3R)-4-tert-butoxy-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoic acid
  • (3R)-4-tert-butoxy-3-[(9H-fluoren-9-ylmethoxy-oxomethyl)amino]-4-oxobutanoic acid
  • (3R)-4-tert-butoxy-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-keto-butyric acid
  • (3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxo-butanoic acid
InChIKey VZXQYACYLGRQJU-LJQANCHMSA-N
InChI InChI=1S/C23H25NO6/c1-23(2,3)30-21(27)19(12-20(25)26)24-22(28)29-13-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,24,28)(H,25,26)/t19-/m1/s1
SMILES CC(C)(C)OC(=O)[C@@H](CC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
Cited Uses

Details

1. Kenyon NJ et al, "Self-Assembling Nanoparticles Containing Dexamethasone as a Novel Therapy in Allergic Airways Inflammation", PLoS ONE, 8(10) pp.e77730 ().
2. Aki K et al, "Kinetics of Isomerization and Inversion of Aspartate 58 of ?A-Crystallin Peptide Mimics under Physiological Conditions", PLoS ONE, 8(3) pp.e58515 ().
3. Fujii N et al, "A Rapid, Comprehensive Liquid Chromatography-Mass Spectrometry (LC-MS)-based Survey of the Asp Isomers in Crystallins from Human Cataract Lenses", The Journal of Biological Chemistry, 287(47) pp.39992-40002 (2012 Nov 16).
4. Aki K et al, "Characterization of an antibody that recognizes peptides containing D-?-aspartyl residues", Molecular Vision, 18() pp.996-1003 ().
5. Xiao K et al, "The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles", Biomaterials, 32(13) pp.3435-3446 (2011 May).
6. Wang D et al, "Pharmacokinetic and Biodistribution Studies of a Bone-targeting Drug Delivery System Based on N-(2-Hydroxypropyl)methacrylamide (HPMA) Copolymers", Molecular pharmaceutics, 3(6) pp.717-725 (2006).
Reviews
cr